Intracerebroventricular administration of anti-leucine-rich glioma inactivated-1 protein antibody increases seizure susceptibility and impairs memory in rats

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYilmaz, N. Carcak
dc.contributor.authorPiskin, S. Akat
dc.contributor.authorYuceer, H.
dc.contributor.authorUlusoy, C.
dc.contributor.authorKucukali, C. I.
dc.contributor.authorOnat, F.
dc.contributor.authorTuzun, E.
dc.date.accessioned2025-10-16T15:14:18Z
dc.date.issued2023
dc.description.abstract35th International Epilepsy Congress, Dublin, IRELAND, SEP 02-06, 2023
dc.identifier.otherWOS:001183972501119
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6127
dc.publisherWILEY
dc.sourceEPILEPSIA
dc.titleIntracerebroventricular administration of anti-leucine-rich glioma inactivated-1 protein antibody increases seizure susceptibility and impairs memory in rats
dc.typeMeeting Abstract

Dosyalar

Koleksiyonlar

WOS